Helicobacter Pylori Non-Invasive Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Test Type, Test Method, and End User

Description

List of Tables

The Helicobacter Pylori (H. pylori) Non-Invasive Testing market is expected to grow from US$ 596.82 million in 2021 to US$ 800.04 million by 2028; it is estimated to grow at a CAGR of 4.4% from 2022 to 2028.

Increasing prevalence of H. pylori bacterial infection, spreading awareness among individuals regarding the diagnosis of H. pylori, and new product launches & FDA approvals fuel the overall market growth.

The prevalence of the gastric disease is significantly higher in the geriatric population as aging increases the risk of H. pylori infection. Increased age leads to thinning of the stomach lining, thus allowing the bacteria to pass through the protective lining that contributes to the growing prevalence of infection among older people. According to World Health Organization (WHO), the population percentage aged 60 years and above is expected to be 13.7% globally and 20.3% in the south-east Asia region by 2030. With the subsequent increase in the geriatric population, the demand for primary care services, including screening, assessment, and management of clinical and functional comorbidities, is increasing. These statistics determine an increase in the need for diagnostics in various regions across the globe, which is boosting the growth of the Helicobacter pylori (H. pylori) non-invasive testing market during the forecast period.

Helicobacter Pylori (H. pylori) Non-Invasive Testing Market: Segmental Overview

Based on the test type, the Helicobacter pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breath. The urea breath segment held the largest market share in 2021, and it is anticipated to register the highest CAGR during the forecast period owing to rising product development trends among prominent players. Based on test method, the Helicobacter pylori (H. pylori) non-invasive testing market is bifurcated into laboratory-based and point-of-care. In 2021, the laboratory-based segment held a larger market share, and it is expected to register a higher CAGR from 2022 to 2028 due to the healthcare professionals operating with testing procedures, making the diagnostics procedures more accurate. Based on end users, the Helicobacter pylori (H. pylori) non-invasive testing market is segmented into hospitals, clinics, and diagnostic laboratories. In 2021, the diagnostic laboratories segment held the largest share of the market, and it is expected to register the highest CAGR from 2022 to 2028, owing to the increasing number of tests carried out in labs and rising competition in the industry demands competitive prices and the best possible services.

Helicobacter Pylori (H. pylori) Non-Invasive Testing Market: Geographical Overview

North America holds the largest share of the global Helicobacter Pylori (H. pylori) non-invasive testing market, whereas Asia Pacific is the fastest-growing region. The market in North America is expected to grow during the forecast period owing to the growing prevalence of stomach cancer, duodenal ulcers, and gastric ulcers and the development of health care facilities.

Asia Pacific is likely to register the highest CAGR in the global H. pylori non-invasive testing market during the forecast period. The market in the region is expected to grow significantly in various countries, including China, India, and Japan, in the coming years. The Asia Pacific Helicobacter Pylori (H. pylori) non-invasive testing market is expected to grow due to the rising geriatric population, high prevalence of H. pylori, and gastric cancer cases. Therefore, the region holds huge potential for the market players to grow during the forecast period.

Market Opportunities of Helicobacter Pylori (H. pylori) Non-Invasive Testing Market

The different conferences and events held globally by various organizations and institutes make people aware of H. pylori infections and give an overview of appropriate vital screening, early diagnosis of infection, and its effective cutting-edge treatment in successfully eradicating the infection. Participants in these conferences/events utilize these learnings to develop a framework for introducing H. pylori testing devices for their family practice and healthcare facilities. For instance, in February 2019, a conference "Helicobacter pylori Update Conference" was held in Abu Dhabi by the MENA conference. This conference offered the opportunity to meet, listen to and interact with world-class scientific and clinical research, public health, and industry experts.

The increasing awareness of H. pylori infections such as peptic ulcers and gastritis is bringing the test diagnostics kits conveniently and quickly to the patient at home, which is also providing growth opportunities to the Helicobacter Pylori (H. pylori) non-invasive testing market. Many clinicians recognize point-of-care (POC) testing as a requirement for the early detection of life-threatening situations because the results can be made available in real-time. In low- and middle-income countries, POC diagnostic and monitoring devices are anticipated to become universal in-home setups and at doctor's offices or hospitals. Also, various companies are offering test kits for home use; for instance, Labsystems Diagnostics offers Biocard Helicobacter pylori IgG an immunochromatographic test for the detection of H. pylori IgG antibodies at home. Thus, various initiative to spread awareness among individuals for diagnosis of H. pylori along with the rising use of POC testing methods across the world is likely to create lucrative growth opportunities for the Helicobacter Pylori (H. pylori) non-invasive testing market in the coming years.

The World Health Organization (WHO), Globocan, World Bank Data, National Health Service (NHS), PubMed Central, and National Center for Biotechnology Information (NCBI) are a few secondary sources referred to while preparing the report on the global Helicobacter Pylori (H. pylori) non-invasive testing market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the H. pylori non-invasive testing market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global H. pylori non-invasive testing market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: TIPRE00005185

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market - By Test Type
- 1.3.2 Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market - By Test Method
- 1.3.3 Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market - By End User
- 1.3.4 Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market - By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East & Africa PEST Analysis
- 4.2.5 South & Central America PEST Analysis
4.3 Experts Opinion

5. Helicobacter Pylori (H. pylori ) Non-Invasive Testing Market - Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Increasing prevalence of H. pylori bacterial infection
- 5.1.2 New Product Launches & FDA Approvals for Noninvasive Tests
- 5.1.3 Spreading Awareness Among Individuals Regarding Diagnosis of H. pylori
- 5.1.4 Rise in Investments by Pharmaceutical Companies
5.2 Key Market Restraints
- 5.2.1 Low Diagnosis Rate
5.3 Key Market Opportunities
- 5.3.1 Increasing Number of Conferences and Events for Research
- 5.3.2 Introduction of Artificial Intelligence
5.4 Future Trends
- 5.4.1 Increasing Use of Home-Based POC Devices
- 5.4.2 Diagnosis for Resistance
5.5 Impact Analysis

6. Helicobacter pylori (H. pylori) Non-Invasive Testing Market- Global Analysis

6.1 Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue Forecast and Analysis
6.2 Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
6.4 Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market - Market Potential Analysis, By Region
6.5 Comparative Company Analysis
6.6 Growth Strategy Analysis
6.7 Performance of Key Players
- 6.7.1 Abbott
- 6.7.2 DiaSorin S.p.A.

7. Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market Analysis- by Test Type

7.1 Overview
7.2 Global Helicobacter pylori (H. pylori) Non-invasive Testing Market, By Test Type 2022 & 2028 (%)
7.3 Serology Test
- 7.3.1 Overview
- 7.3.2 Global Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Stool Antigen Test
- 7.4.1 Overview
- 7.4.2 Global Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Urea Breath Test
- 7.5.1 Overview
- 7.5.2 Global Urea Breath Test Market Revenue and Forecasts to 2028 (US$ Mn)

8. Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market Analysis- by Test Method

8.1 Overview
8.2 Global Helicobacter pylori (H. pylori) Non-invasive Testing Market, By Test Method 2022 & 2028 (%)
8.3 Laboratory Based Tests
- 8.3.1 Overview
- 8.3.2 Global Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)
8.4 Point Of Care Tests
- 8.4.1 Overview
- 8.4.2 Global Point Of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)

9. Global Helicobacter pylori (H. pylori) Noninvasive Testing Market Analysis- by End User

9.1 Overview
9.2 Global Helicobacter pylori (H. pylori) Non-invasive Testing Market, By End User 2018 & 2028 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Global Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Clinics
- 9.4.1 Overview
- 9.4.2 Global Clinics Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Diagnostic Laboratories
- 9.5.1 Overview
- 9.5.2 Global Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

10. Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 - Geographical Analysis

10.1 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market
- 10.1.1 Overview
- 10.1.2 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.3 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type, 2020-2028 (US$ Million)
- 10.1.4 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method, 2020-2028 (US$ Million)
- 10.1.5 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User, 2020-2028 (US$ Million)
- 10.1.6 North America: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
  - 10.1.6.1 US: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.1.1 Overview
    - 10.1.6.1.2 US: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.1.3 US: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type, 2020-2028 (US$ Million)
    - 10.1.6.1.4 US: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method, 2020-2028 (US$ Million)
    - 10.1.6.1.5 US: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User, 2020-2028 (US$ Million)
  - 10.1.6.2 Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.2.1 Overview
    - 10.1.6.2.2 Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.2.3 Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type, 2020-2028 (US$ Million)
    - 10.1.6.2.4 Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method, 2020-2028 (US$ Million)
    - 10.1.6.2.5 Canada: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User, 2020-2028 (US$ Million)
  - 10.1.6.3 Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.3.1 Overview
    - 10.1.6.3.2 Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.3.3 Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type, 2020-2028 (US$ Million)
    - 10.1.6.3.4 Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method, 2020-2028 (US$ Million)
    - 10.1.6.3.5 Mexico: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User, 2020-2028 (US$ Million)
10.2 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market
- 10.2.1 Overview
- 10.2.2 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
- 10.2.3 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
- 10.2.4 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
- 10.2.5 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- 10.2.6 Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
  - 10.2.6.1 Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.1.1 Overview
    - 10.2.6.1.2 Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.1.3 Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.1.4 Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.1.5 Germany: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  - 10.2.6.2 France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.2.1 Overview
    - 10.2.6.2.2 France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.2.3 France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.2.4 France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.2.5 France: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  - 10.2.6.3 UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.3.1 Overview
    - 10.2.6.3.2 UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.3.3 UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.3.4 UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.3.5 UK: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  - 10.2.6.4 Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.4.1 Overview
    - 10.2.6.4.2 Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.4.3 Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.4.4 Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.4.5 Italy: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  - 10.2.6.5 Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.5.1 Overview
    - 10.2.6.5.2 Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.5.3 Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.5.4 Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.5.5 Spain: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  - 10.2.6.6 Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.6.1 Overview
    - 10.2.6.6.2 Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.6.3 Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.6.4 Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Test Method- Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.6.5 Rest of Europe: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
10.3 Asia Pacific Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts To 2028
- 10.3.1 Overview
- 10.3.2 Asia Pacific Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
- 10.3.3 Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
- 10.3.4 Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
- 10.3.5 Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
- 10.3.6 Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028, By Country, 2022 & 2028 (%)
  - 10.3.6.1 China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.1.1 Overview
    - 10.3.6.1.2 China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.1.3 China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
    - 10.3.6.1.4 China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
    - 10.3.6.1.5 China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
  - 10.3.6.2 Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.2.1 Overview
    - 10.3.6.2.2 Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.2.3 Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
    - 10.3.6.2.4 Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
    - 10.3.6.2.5 Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
  - 10.3.6.3 India Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.3.1 Overview
    - 10.3.6.3.2 India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.3.3 India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
    - 10.3.6.3.4 India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
    - 10.3.6.3.5 India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
  - 10.3.6.4 South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.4.1 Overview
    - 10.3.6.4.2 South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.4.3 South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
    - 10.3.6.4.4 South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
    - 10.3.6.4.5 South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
  - 10.3.6.5 Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.5.1 Overview
    - 10.3.6.5.2 Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.5.3 Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
    - 10.3.6.5.4 Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
    - 10.3.6.5.5 Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
  - 10.3.6.6 Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.6.1 Overview
    - 10.3.6.6.2 Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.6.3 Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By Test Type - 2019-2028 (US$ Million)
    - 10.3.6.6.4 Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method - 2019-2028 (US$ Million)
    - 10.3.6.6.5 Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, By End User - 2019-2028 (US$ Million)
10.4 Middle East & Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market
- 10.4.1 Overview
- 10.4.2 Middle East & Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
- 10.4.3 Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
- 10.4.4 Middle East & Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts to 2028, By Test Method (US$ Million)
- 10.4.5 Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- 10.4.6 Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
  - 10.4.6.1 UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (USD Million)
    - 10.4.6.1.1 Overview
    - 10.4.6.1.2 UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.1.3 UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 10.4.6.1.4 UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
    - 10.4.6.1.5 UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts To 2028, By End User (US$ Million)
  - 10.4.6.2 Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (USD Million)
    - 10.4.6.2.1 Overview
    - 10.4.6.2.2 Saudi Arabia Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.2.3 Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 10.4.6.2.4 Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
    - 10.4.6.2.5 Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts To 2028, By End User (US$ Million)
  - 10.4.6.3 South Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (USD Million)
    - 10.4.6.3.1 Overview
    - 10.4.6.3.2 South Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.3.3 South Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 10.4.6.3.4 South Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
    - 10.4.6.3.5 South Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts To 2028, By End User (US$ Million)
  - 10.4.6.4 Rest of the Middle East and Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market - Revenue and Forecast to 2028 (USD Million)
    - 10.4.6.4.1 Overview
    - 10.4.6.4.2 Rest of the Middle East and Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
    - 10.4.6.4.3 Rest of Middle East & Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 10.4.6.4.4 Rest of Middle East & Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
    - 10.4.6.4.5 Rest of Middle East & Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.5 South And Central America Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue And Forecasts To 2028
- 10.5.1 South and Central America Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
- 10.5.2 South and Central America Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)
- 10.5.3 South and Central America Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue And Forecasts To 2028, By Test Method (US$ MN)
- 10.5.4 South and Central America Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue And Forecasts to 2028, By End User (US$ Mn)
- 10.5.5 South and Central America Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Country (%)
  - 10.5.5.1 Argentina Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    - 10.5.5.1.1 Argentina Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    - 10.5.5.1.2 Argentina Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)
    - 10.5.5.1.3 Argentina Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue And Forecasts To 2028, By Test Method (US$ MN)
    - 10.5.5.1.4 Argentina Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue And Forecasts to 2028, By End User (US$ Mn)
  - 10.5.5.2 Brazil Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    - 10.5.5.2.1 Brazil Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    - 10.5.5.2.2 Brazil Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028, By Test (US$ Mn)
    - 10.5.5.2.3 Brazil Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts To 2028, By Test Method (US$ MN)
    - 10.5.5.2.4 Brazil Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028, By End User (US$ Mn)
  - 10.5.5.3 Rest of South and Central America Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    - 10.5.5.3.1 RoSCAM Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)
    - 10.5.5.3.2 RoSCAM Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)
    - 10.5.5.3.3 RoSCAM Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue And Forecasts To 2028, By Test Method (US$ MN)
    - 10.5.5.3.4 RoSCAM Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue And Forecasts to 2028, By End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on H. pylori Non-Invasive Testing Market

11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. Company Profile

13.1 DiaSorin S.p.A.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Meridian Bioscience, Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 QuidelOrtho Corporation
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Abbott Laboratories
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Thermo Fisher Scientific Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 CerTest Biotec
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Sekisui Diagnostics
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Coris BioConcept
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Bio-Rad Laboratories, Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms